Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Tigatuzumab)
Catalog No.
F1044
Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Tigatuzumab)
Featured Products
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targeting death receptor 5 (DR5). Tigatuzumab can induce apoptosis in cancer cells and inhibit tumor growth in vivo. Tigatuzumab can be used in cancer research.
145 kDa
Dry ice
918127-53-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CS-1008, TRA-8, DS-8273
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O14763
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF10B / TRAILR2 / CD262
Please avoid freeze-thaw cycles.